对于高血压的脏缩:目前的证据和临床前景
Jason Li1,2, Joey Chiang3, Lee Bockus2
1Division of Cardiology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Current atherosclerosis reports
|August 12, 2025
概括
高血压控制已经停滞不前,女性和少数群体受到影响的差异. 脏缩 (RDN) 显示出作为辅助治疗的希望,但为了公平使用,需要更多的研究.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 血管医学 血管医学
背景情况:
- 高血压仍然是心血管疾病和死亡的主要驱动因素.
- 控制高血压的进展停滞不前,严重的治疗不足影响高风险人群,包括妇女和少数群体.
- 现有的药理疗法存在局限性,需要探索替代治疗策略.
研究的目的:
- 审查当前关于高血压诊断和治疗的文献.
- 突出高血压护理现有的差异.
- 批判性地评估最近对脏缩 (RDN) 的随机对照试验 (RCT),并定义其在高血压管理中的作用.
主要方法:
- 关于高血压诊断和治疗的综合文献综述.
- 对最近的随机对照试验 (RCT) 的分析,重点是脏缩 (RDN).
- 评估RDN在不同患者群体中的有效性,安全性和适用性.
主要成果:
- 尽管有进展,但高血压控制率停滞不前,在护理方面存在显著的差异.
- 使用射频和超声波的脏缩 (RDN) 在最近的RCT中证明了降低血压的有效性.
- 越来越多地考虑将RDN纳入临床实践指南,作为辅助疗法.
结论:
- 脏缩 (RDN) 是一种有前途的程序选择,用于管理抗性高血压.
- 确保公平获取和了解代表性不足的人群的长期结果对于 RDN 实施至关重要.
- 进一步的研究是必要的,以确认 RDN 在不同患者群体的长期安全性,有效性和影响.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
508
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
508
01:25Antihypertensive Drugs: Direct Renin Inhibitors
823
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
823
01:16Antihypertensive Drugs: Action of Diuretics
871
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
871
01:18Hypertension and Regulation of Blood Pressure
3.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.1K
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
881
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
881
01:29Hypertension II: Pathophysiology
78
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
78